The CDC said an investigation into a human H5N1 bird flu infection in Missouri has found four additional health care workers ...

Get your daily dose of health and medicine every weekday with STAT’s free newsletter Morning Rounds. Sign up here. In a new ...

Dhillon is an instructor in the Division of Global Health Equity at Brigham and Women’s Hospital and Harvard Medical School.

After Pfizer withdrew its sickle cell drug from the market, patients with the condition and their doctors were left ...

MedStar executive Raj Ratwani says the idea of shared responsibility should be central to how health AI is regulated.

A dispute over a Duchenne gene therapy highlights thorny issues surrounding FDA approvals and insurance policies.

What comes next for Pfizer's Oxbryta sickle cell drug —Cassava Sciences' SEC charges —Bristol's new schizophrenia treatment ...

Particle Health's antitrust lawsuit is a direct threat to Epic Systems' dominance in the multi-billion dollar market for ...

Biden administration officials have abandoned their own proposal to require drug companies to disclose the prices and ...

Pfizer is removing its Oxbryta pill for sickle cell disease from all markets globally due to safety risks, including deaths.

There hasn’t been a new class of drugs approved to help smokers quit since Pfizer's Chantix reached the market nearly two ...

Cobenfy was approved to reduce the psychotic symptoms associated with schizophrenia. It is a new type of medicine that works ...